接近诱导核酸降解剂 (PINAD) 方法用于使用小分子向RNA降解
Sigitas Mikutis1, Maria Rebelo2, Eliza Yankova3,4
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.
ACS central science
|May 30, 2023
概括
研究人员开发了近距离诱导的核酸降解剂 (PINADs),以使用小分子准和降解RNA. 这种新方法在各种模型中有效降解SARS-CoV-2RNA,提供了一种新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在RNA治疗方面,RNA疗法.
- 药物发现 药物发现 药物发现
背景情况:
- 针对RNA的治疗方法,如小干扰RNA和RNase H诱导的寡核酸,为以蛋白为中心的方法提供了替代方案.
- 基于核酸的治疗方法面临诸多挑战,包括细胞吸收和稳定性不佳.
- 现有的RNA向策略在向各种RNA结构方面存在局限性.
研究的目的:
- 开发一种新的基于小分子的方法来准和降解特定的RNA结构.
- 设计和验证针对SARS-CoV-2RNA标的近距离诱导核酸降解剂 (PINADs).
- 在各种感染模型中证明PINADs的治疗潜力.
主要方法:
- 设计和合成两个家族的小分子RNA降解剂 (PINADs).
- 针对SARS-CoV-2RNA结构,包括G-四重复和β冠状病毒伪结.
- 使用体外,细胞内和体内SARS-CoV-2感染模型验证RNA降解功效.
主要成果:
- 皮纳德成功降解了向的SARS-CoV-2RNA结构在体外,细胞内和体内.
- 在临床前的SARS-CoV-2感染模型中,PINAD策略证明了其有效性.
- 这种方法可以将RNA结合的小分子转化为强大的RNA降解剂.
结论:
- 靠近诱导的核酸降解剂 (PINADs) 是一种用于RNA降解的新多功能平台.
- 这一策略克服了传统的基于核酸的治疗方法的局限性.
- 皮纳德扩大了可用药的RNA标的范围,有可能解决更广泛的疾病.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.6K
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.8K
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Types of RNA
64.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.1K
mRNA Stability and Gene Expression
5.7K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.7K
Nonsense-mediated mRNA Decay
10.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
